SCHEMBL7961440

SCHEMBL7961440

N#Cc1c(C(N)=O)c2n(c1-c1cccnc1F)CCCC2O

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.35
RECQL P46063 1/20 0.35
KCNMA1 Q12791 3/20 0.34
PLAU P00749 1/20 0.33
PDE4B Q07343 3/20 0.33
PDE4D Q08499 1/20 0.33
ABL1 P00519 2/20 0.32
JAK2 O60674 2/20 0.32
JAK1 P23458 2/20 0.32
BTK Q06187 1/20 0.31
CYP11B2 P19099 2/20 0.31
UCHL1 P09936 1/20 0.31
MKNK1 Q9BUB5 1/20 0.31
MKNK2 Q9HBH9 1/20 0.31
ELANE P08246 1/20 0.30
SLC18A3 Q16572 1/20 0.30
FPR1 P21462 1/20 0.30
FPR2 P25090 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8327934 0.91 DHODH (0.35) KDM4ERECQLKCNMA1PDE4BPDE4D
SCHEMBL7963132 0.90 PDE4B (0.34) KDM4ERECQLKCNMA1PDE4BPDE4D
SCHEMBL7964348 0.88 KDM4E (0.35) KDM4ERECQLKCNMA1PDE4BBTK
SCHEMBL7962855 0.88 HCRTR1 (0.37) KCNMA1PDE4BPDE4DABL1
SCHEMBL7961767 0.87 KCNMA1 (0.38) KDM4ERECQLKCNMA1PDE4BPDE4D
SCHEMBL7961217 0.85 FPR1 (0.35) PLAUPDE4BPDE4DABL1MKNK1
SCHEMBL7953432 0.85 MKNK1 (0.37) KDM4EPLAUABL1MKNK1MKNK2
SCHEMBL7962948 0.83 PLAU (0.35) KDM4EPLAUABL1MKNK1MKNK2
SCHEMBL7963165 0.82 SCN9A (0.34) PLAUABL1MKNK1MKNK2
SCHEMBL7953127 0.82 KCNMA1 (0.36) KCNMA1PDE4BPDE4DABL1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US claimed
EP-0946555-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM Aventis Pharma S.A. (FR) 1999-10-06 EP claimed
WO-1998025925-A1 PYRROLE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1998-06-18 WO claimed
US-6207675-B1 FOR PROPHYLAXIS AND THERAPY OF DISEASES IN WHICH ARE INVOLVED VIRUSES OF THE HERPES FAMILY AND/OR CYTOKINES IN PARTICULAR TUMOR NERCOSIS FACTOR-ALPHA RHONE-POULENC RORER S.A. (FR) 2001-03-27 US disclosed